These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17704359)

  • 1. Functional VEGF and VEGF receptors are expressed in human medulloblastomas.
    Slongo ML; Molena B; Brunati AM; Frasson M; Gardiman M; Carli M; Perilongo G; Rosolen A; Onisto M
    Neuro Oncol; 2007 Oct; 9(4):384-92. PubMed ID: 17704359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
    Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
    Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
    Wey JS; Fan F; Gray MJ; Bauer TW; McCarty MF; Somcio R; Liu W; Evans DB; Wu Y; Hicklin DJ; Ellis LM
    Cancer; 2005 Jul; 104(2):427-38. PubMed ID: 15952180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
    Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
    Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
    Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
    J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.
    Schmidt M; Voelker HU; Kapp M; Dietl J; Kammerer U
    Anticancer Res; 2008; 28(3A):1719-24. PubMed ID: 18630531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
    Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors.
    Qi L; Robinson WA; Brady BM; Glode LM
    Anticancer Res; 2003; 23(5A):3917-22. PubMed ID: 14666697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
    Gaumann A; Groot M; Drexler HC; Breier G
    Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
    Weigand M; Hantel P; Kreienberg R; Waltenberger J
    Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.
    Fan F; Wey JS; McCarty MF; Belcheva A; Liu W; Bauer TW; Somcio RJ; Wu Y; Hooper A; Hicklin DJ; Ellis LM
    Oncogene; 2005 Apr; 24(16):2647-53. PubMed ID: 15735759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.
    Herold-Mende C; Steiner HH; Andl T; Riede D; Buttler A; Reisser C; Fusenig NE; Mueller MM
    Lab Invest; 1999 Dec; 79(12):1573-82. PubMed ID: 10616207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coexpression of vascular endothelial growth factor and its receptors in human tumor cell lines].
    Fu JX; Wang W; Bai X; Wang L; Zhu ZL; Chen ZX; Ruan CG
    Ai Zheng; 2002 Nov; 21(11):1217-21. PubMed ID: 12526219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
    Lacal PM; Ruffini F; Pagani E; D'Atri S
    Int J Oncol; 2005 Dec; 27(6):1625-32. PubMed ID: 16273219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.
    Tanno S; Ohsaki Y; Nakanishi K; Toyoshima E; Kikuchi K
    Lung Cancer; 2004 Oct; 46(1):11-9. PubMed ID: 15364128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
    List AF; Glinsmann-Gibson B; Stadheim C; Meuillet EJ; Bellamy W; Powis G
    Exp Hematol; 2004 Jun; 32(6):526-35. PubMed ID: 15183893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer.
    Nakanishi R; Oka N; Nakatsuji H; Koizumi T; Sakaki M; Takahashi M; Fukumori T; Kanayama HO
    Urol Int; 2009; 83(1):98-106. PubMed ID: 19641368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.
    Kim SJ; Seo JH; Lee YJ; Yoon JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Oncology; 2005; 68(2-3):204-11. PubMed ID: 16015035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.